More than 3 billion people worldwide are at risk of acquiring malaria and pregnant women living with HIV in Africa are at particular risk. An effective prophylaxis regimen capable of preventing malaria and other common perinatal infections would have great potential to improve adverse birth outcomes. The purpose of this randomized controlled trial is to evaluate a new combination prophylaxis regimen in pregnant women with HIV in Cameroon to determine its efficacy and safety.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Plasmodium Falciparum Peripheral Parasitemia
Timeframe: At end of pregnancy (>35 weeks) or at delivery
Proportion With Composite STI Outcome
Timeframe: will be measured in both groups (>35 weeks) or at delivery